INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 92 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,768,130 | -18.6% | 149,129 | -1.1% | 1.25% | -8.6% |
| Q2 2023 | $9,548,213 | +19.2% | 150,793 | +2.0% | 1.37% | +12.8% |
| Q1 2023 | $8,008,568 | +6.0% | 147,896 | +3.6% | 1.22% | -1.8% |
| Q4 2022 | $7,553,854 | +12.7% | 142,741 | -0.9% | 1.24% | +7.4% |
| Q3 2022 | $6,702,000 | +0.7% | 144,038 | +23.5% | 1.15% | +1.4% |
| Q2 2022 | $6,658,000 | +9.7% | 116,646 | -38.9% | 1.14% | +76.9% |
| Q4 2020 | $6,068,000 | -26.2% | 190,833 | -25.8% | 0.64% | -45.8% |
| Q2 2015 | $8,219,000 | – | 257,256 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |